Finger-prick sampling for the monitoring of tacrolimus, creatinine and hemoglobin in kidney transplant recipients

Laboratory and clinical perspectives of finger-prick sampling after kidney transplantation

Finger-prick sampling emerges as an attractive tool for therapeutic drug monitoring and associated diagnostics during follow-up in different patient populations. Kidney transplant recipients constitute a group with likely valuable gain from this concept. It is necessary to meet requirements for quality, efficiency, user-friendliness and new forms of interaction in order to achieve successful implementation in clinical practice. Aspects related to technical operations and quality, factors important for success, as well as identified challenges will be highlighted in this webinar.

Will be of interest to:Hospitals that consider development/implementation of home-sampling
Laboratories involved in therapeutic drug monitoring
Clinicians involved in therapeutic drug monitoring, especially nephrologists
Researchers interested in new concepts for therapeutic drug monitoring and diagnostics


Speakers: Nils Tore Vethe (Head of Section, Department of Pharmacology, Oslo University Hospital) and Karsten Midtvedt (Senior physician in Nephrology, Department of Transplantation Medicine, Oslo University Hospital)
​​​​​​​
​​​​​​​In Association with the Patient Centric Sampling Interest Group, and sponsored by Alturas Analytics, Capitainer, Genentech, RedDrop Dx, Roche, Tasso, ​​​​​Veloxity Labs and YouBio Health.

Your details

By submitting this form you are agreeing to our Terms & Conditions and Privacy Policy, and agree to receiving relevant emails from The Evidence Base about the latest news and editorial features.

Terms & Conditions

I agree to receive third party emails to keep me informed of relevant products and services relevant to my industry.

I agree for my registration data to be transferred to the lead partner organization (PCSIG).

Subscribing to

Confirm sign-up

What you will learn:

How can finger-prick sampling be used in the follow-up of kidney transplant recipients
How is the quality compared to ordinary venous blood samples
Important aspects for the laboratory
Important aspects for the clinician

Moderated by:

Neil Spooner
Director, Spooner Bioanalytical Solutions

Neil is the Founder of Spooner Bioanalytical Solutions, helping companies to integrate biological fluid microsampling, and patient centric sampling and analysis into workflows. He also works with organisations to develop technologies and introduce them to the market. Neil also assists organisations with their understanding of emerging trends in the pharmaceutical industry and bioanalysis. Neil is a Senior Visiting Research Fellow at the University of Hertfordshire, Editor in Chief of the journal, Bioanalysis, Founder of the Patient Centric Sampling Interest Group and Co-Chair of the Reid Bioanalytical Forum. He has published over 70 peer reviewed manuscripts and delivered over 50 podium presentations.

Speakers:

Nils Tore Vethe
Head of Section, Department of Pharmacology, Oslo University Hospital

Nils Tore Vethe (MScPharm, PhD) is Section Manager at Clinical Pharmacology – Rikshospitalet, Oslo University Hospital. His research focus in recent years has been related to the development of pharmacological methods that can simplify and improve the follow-up of transplant recipients as well as the development of pharmacological tools adapted for patients with cardiovascular diseases. Innovative development of laboratory operations based on analytical methods for self-performed finger-prick sampling, technological modernization supported by automation processes, as well as development and utilization of digital interactions are in the main areas of interest.

Karsten Midtvedt
Senior physician in Nephrology, Department of Transplantation Medicine, Oslo University Hospital

Karsten Midtvedt (MD, PhD) is Senior Physician at the Department of Transplantation Medicine with speciality in nephrology. He has long and extensive experience with follow-up of kidney transplant recipients. His research interests include the development of new tools that facilitate improved follow-up and effective immunosuppressive treatment. He has been the principal investigator with clinical responsibility and led the clinical implementation of therapeutic drug monitoring based on finger-prick sampling in kidney transplant patients.

Share this webinar